Key result
Heart failure disease management programs demonstrated inconsistent efficacy in reducing hospital readmissions and mortality, suggesting interventions must be individualized to specific patient needs.
Why the study?
Do heart failure disease management programs reduce hospitalizations and mortality in patients with chronic heart failure?
Systematic Review
Do heart failure disease management programs reduce hospitalizations and mortality in patients with chronic heart failure?
Heart failure disease management programs show inconsistent efficacy in reducing readmissions, suggesting that interventions should be tailored to individualized patient needs rather than applied broadly.
Tailored HF programs may be warranted; challenges broad standardized implementation.
The recent enactment of the Patient Protection and Affordable Care Act which established the federal Hospital Readmissions Reduction Program (HRRP) has accelerated efforts to develop heart failure (HF) disease management programs (DMPs) that reduce readmissions in patients hospitalized for HF. This systematic review identified randomized controlled trials of HF DMPs which included home care, outpatient clinic interventions, structured telephone support, and non-invasive and invasive telemonitoring. These different types of DMPs have been associated with conflicting results. No specific type of DMP has produced consistent benefit in reducing HF hospitalizations. Although probably effective at reducing readmissions, home visits and outpatient clinic interventions have substantial limitations including cost and accessibility. Telemanagement has the potential to reach a large number of patients at a reasonable cost. Structured telephone support follow-up has been shown to significantly reduce HF readmissions, but does not significantly reduce all-cause mortality or all-cause hospitalization. A meta-analysis of 11 non-invasive telemonitoring studies demonstrated significant reductions in all-cause mortality and HF hospitalizations. Invasive telemonitoring is a potentially effective means of reducing HF hospitalizations, but only one study using pulmonary artery pressure monitoring was able to demonstrate a reduction in HF hospitalizations. Other studies using invasive hemodynamic monitoring have failed to demonstrate changes in rates of readmission or mortality. The efficacy of HF DMPs is associated with inconsistent results. Our review should not be interpreted to indicate that HF DMPs are universally ineffective. Rather, our data suggest that one approach applied to a broad spectrum of different patient types may produce an erratic impact on readmissions and clinical outcomes. HF DMPs should include the flexibility to meet the individualized needs of specific patients.
No takes yet. Share an insight, caveat, or question.
Gorthi et al. (2014) conducted a systematic review in Heart failure. Disease management programs (home care, outpatient clinics, telephone support, telemonitoring) vs. Usual care was evaluated on Hospital readmissions and mortality. Heart failure disease management programs demonstrated inconsistent efficacy in reducing hospital readmissions and mortality, suggesting interventions must be individualized to specific patient needs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: